| AASLD

Home

Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti–Programmed Cell Death‐1 in HCC

Read more about Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti–Programmed Cell Death‐1 in HCC

Chenhe Yi, Lirong Chen, Zhifei Lin, Lu Liu, Weiqing Shao, Rui Zhang, Jing Lin, Jubo Zhang, Wenwei Zhu, Huliang Jia, Lunxiu Qin, Lu Lu, Jinhong Chen – 25 May 2021

Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B

Read more about Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B

Edward Gane, Man‐Fung Yuen, Dong Joon Kim, Henry Lik‐Yuen Chan, Bernadette Surujbally, Vedran Pavlovic, Sudip Das, Miriam Triyatni, Remi Kazma, Joseph F. Grippo, Simon Buatois, Annabelle Lemenuel‐Diot, Ben‐Fillippo Krippendorff, Henrik Mueller, Yuchen Zhang, Hyung Joon Kim, Apinya Leerapun, Tien Huey Lim, Young‐Suk Lim, Tawesak Tanwandee, Won Kim, Wendy Cheng, Tsung‐Hui Hu, Cynthia Wat – 25 May 2021

Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient‐Derived Xenograft Models

Read more about Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient‐Derived Xenograft Models

Michael Edward Johnston, Maria Prates Rivas, Delphine Nicolle, Aurore Gorse, Ruhi Gulati, Meenasri Kumbaji, Matthew T. Weirauch, Alexander Bondoc, Stefano Cairo, James Geller, Gregory Tiao, Nikolai Timchenko – 25 May 2021